Kimberly-Clark (KMB) Beat On Earnings, Is The Stock Still Cheap?

كيمبرلي كلارك

Kimberly-Clark Corporation

KMB

0.00

Kimberly-Clark (KMB) is back on investors’ radar after second quarter 2026 results showed an earnings beat driven by cost savings and productivity, a revenue miss, a lower 2026 outlook, and fresh China related profit concerns.

At a share price of US$112.37, Kimberly-Clark has logged a 90 day share price return of 12.87% and a year to date share price return of 10.82%, while the 1 year total shareholder return is down 13.76% as investors weigh China related risks against cost savings, dividend continuity and the hesperaloe fiber program.

If this earnings story has you thinking about where else growth and risk are being repriced, it can help to widen the lens and scan for other consumer facing companies. A practical next step is to see what stands out in our 22 top founder-led companies

Kimberly-Clark appears to be a solid consumer staples business, yet the share price has only just rebounded from a weaker year and still trades at a discount to several value checks. Is that level of caution justified by the current valuation?

Most Popular Narrative: 4% Undervalued

Kimberly-Clark’s most followed narrative places fair value at $117.00 compared to the last close of $112.37, which frames the recent rebound as only a partial catch up.

Disciplined cost management (including targeted SG&A savings, productivity initiatives delivering 5% to 6% of COGS, and digital/automation investments) is enhancing operating efficiency, providing earnings and margin tailwinds that support attainment of multi-year gross margin and operating profit milestones.

Want to see what sits behind that margin story? The narrative leans on steady revenue progress, thicker profit margins, and a re-rated earnings multiple. Curious which assumptions really carry the fair value.

Result: Fair Value of $117.00 (UNDERVALUED)

However, there are still real swing factors here, including tougher private label competition in tissue and diapers, and the risk that ongoing cost cuts weaken Kimberly-Clark’s long term brand strength.

Another View: Kimberly-Clark Through The P/E Lens

The DCF work suggests Kimberly-Clark is trading below an estimate of future cash flow value, yet its P/E of 22.2x tells a more cautious story. That multiple is higher than the global Household Products industry at 16.5x, but lower than peers at 26.9x and beneath a fair ratio of 24.3x. That mix points to some upside if sentiment improves, but also to real re rating risk if earnings disappoint. Which side of that trade off do you think matters more for your time frame?

NasdaqGS:KMB P/E Ratio as at Aug 2026
NasdaqGS:KMB P/E Ratio as at Aug 2026

Next Steps

With mixed sentiment around Kimberly-Clark’s valuation, risks, and recent rebound, it makes sense to look at the data yourself and move quickly to shape your own view using the 2 key rewards and 2 important warning signs.

Looking for more investment ideas beyond Kimberly-Clark?

If you are weighing Kimberly-Clark and want a broader watchlist, now is the time to lock in a few focused screeners so you do not miss other opportunities.

  • Target consistent income by reviewing companies in the 8 dividend fortresses that may help support a long term dividend focused portfolio.
  • Spot potential value opportunities early by scanning the screener containing 17 high quality undiscovered gems before other investors start paying closer attention.
  • Lower portfolio stress by checking which companies in the 79 resilient stocks with low risk scores might help balance out more volatile positions.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.